RT Journal Article
T1 Risk factors for mortality in patients with COVID-19 needing extracorporeal respiratory support.
A1 Riera, Jordi
A1 Alcántara, Sara
A1 Bonilla, Camilo
A1 Fortuna, Phillip
A1 Blandino Ortiz, Aaron
A1 Vaz, Ana
A1 Albacete, Carlos
A1 Millán, Pablo
A1 Ricart, Pilar
A1 Boado, María Victoria
A1 Ruiz de Gopegui, Pablo
A1 Santa Teresa, Patricia
A1 Sandoval, Elena
A1 Pérez-Chomón, Helena
A1 González-Pérez, Alfredo
A1 Duerto, Jorge
A1 Gimeno, Ricardo
A1 Colomina, Joaquín
A1 Gómez, Vanesa
A1 Renedo, Gloria
A1 Naranjo, José
A1 García, Manuel Alfonso
A1 Rodríguez-Ruiz, Emilio
A1 Silva, Pedro Eduardo
A1 Pérez, Daniel
A1 Veganzones, Javier
A1 Voces, Roberto
A1 Martínez, Sergi
A1 Blanco-Schweizer, Pablo
A1 García, Marta
A1 Villanueva-Fernández, Héctor
A1 Fuset, María Paz
A1 Luna, Stephani María
A1 Martínez-Martínez, María
A1 Argudo, Eduard
A1 Chiscano, Luis
A1 Roncon-Albuquerque, Roberto
AB When indicating ECMO in patients with COVID-19, centre case volume, age, driving pressure and the duration of symptoms (not the length of MV) should be taken into account. Large drainage cannula and high PEEP levels during the first days are recommended. https://bit.ly/3DGjGkk
YR 2022
FD 2022-02-10
LK http://hdl.handle.net/10668/20255
UL http://hdl.handle.net/10668/20255
LA en
DS RISalud
RD Apr 8, 2025